Rocket Lab USA [RKLB] vs RTX [RTX] Detailed Stock Comparison
Rocket Lab USA
NASDAQ
Loading...
RTX
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rocket Lab USA wins in 5 metrics, RTX wins in 12 metrics, with 0 ties. RTX appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rocket Lab USA | RTX | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -117.61 | 34.04 | Rocket Lab USA |
| Price-to-Book Ratio | 31.12 | 3.32 | RTX |
| Debt-to-Equity Ratio | 72.35 | 67.86 | RTX |
| PEG Ratio | -194.30 | 25.35 | Rocket Lab USA |
| EV/EBITDA | -111.24 | 17.63 | Rocket Lab USA |
| Profit Margin (TTM) | -45.87% | 7.35% | RTX |
| Operating Margin (TTM) | -41.27% | 11.55% | RTX |
| EBITDA Margin (TTM) | N/A | 11.55% | N/A |
| Return on Equity | -40.45% | 10.32% | RTX |
| Return on Assets (TTM) | -10.13% | 3.70% | RTX |
| Free Cash Flow (TTM) | $-115.98M | $3.92B | RTX |
| Dividend Yield | N/A | 1.30% | N/A |
| 1-Year Return | 732.22% | 33.33% | Rocket Lab USA |
| Price-to-Sales Ratio (TTM) | 42.48 | 2.48 | RTX |
| Enterprise Value | $21.00B | $247.95B | RTX |
| EV/Revenue Ratio | 41.65 | 2.97 | RTX |
| Gross Profit Margin (TTM) | 28.76% | 20.28% | Rocket Lab USA |
| Revenue per Share (TTM) | $1 | $63 | RTX |
| Earnings per Share (Diluted) | $-0.41 | $4.55 | RTX |
| Beta (Stock Volatility) | N/A | 0.67 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Rocket Lab USA vs RTX Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rocket Lab USA | 1.09% | -0.27% | 15.36% | 93.46% | 46.05% | 79.05% |
| RTX | -0.58% | -1.24% | 6.87% | 20.35% | 20.75% | 33.49% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rocket Lab USA | 732.22% | 529.44% | 355.09% | 355.09% | 355.09% | 355.09% |
| RTX | 33.33% | 62.99% | 143.34% | 149.33% | 248.08% | 375.18% |
Performance & Financial Health Analysis: Rocket Lab USA vs RTX
| Metric | RKLB | RTX |
|---|---|---|
| Market Information | ||
| Market Cap | $21.42B | $207.29B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 13,672,272 | 4,342,010 |
| 90 Day Avg. Volume | 21,819,954 | 4,877,743 |
| Last Close | $44.69 | $154.86 |
| 52 Week Range | $4.63 - $53.44 | $112.27 - $158.79 |
| % from 52W High | -16.37% | -2.47% |
| All-Time High | $53.44 (Jul 17, 2025) | $158.79 (Jul 29, 2025) |
| % from All-Time High | -16.37% | -2.47% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.36% | 0.09% |
| Quarterly Earnings Growth | 0.32% | 13.93% |
| Financial Health | ||
| Profit Margin (TTM) | -0.46% | 0.07% |
| Operating Margin (TTM) | -0.41% | 0.12% |
| Return on Equity (TTM) | -0.40% | 0.10% |
| Debt to Equity (MRQ) | 72.35 | 67.86 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.44 | $46.62 |
| Cash per Share (MRQ) | $1.44 | $3.57 |
| Operating Cash Flow (TTM) | $-110,769,000 | $5.85B |
| Levered Free Cash Flow (TTM) | $-99,876,000 | $2.80B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.30% |
| Last 12-Month Dividend | N/A | $1.89 |
Valuation & Enterprise Metrics Analysis: Rocket Lab USA vs RTX
| Metric | RKLB | RTX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -117.61 | 34.04 |
| Forward P/E | -194.30 | 25.35 |
| PEG Ratio | -194.30 | 25.35 |
| Price to Sales (TTM) | 42.48 | 2.48 |
| Price to Book (MRQ) | 31.12 | 3.32 |
| Market Capitalization | ||
| Market Capitalization | $21.42B | $207.29B |
| Enterprise Value | $21.00B | $247.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 41.65 | 2.97 |
| Enterprise to EBITDA | -111.24 | 17.63 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.67 |
| Book Value per Share (MRQ) | $1.44 | $46.62 |
Financial Statements Comparison: Rocket Lab USA vs RTX
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RKLB | RTX |
|---|---|---|
| Revenue/Sales | $122.57M | $20.31B |
| Cost of Goods Sold | $87.32M | $16.19B |
| Gross Profit | $35.25M | $4.12B |
| Research & Development | $55.11M | $637.00M |
| Operating Income (EBIT) | $-59.19M | $2.04B |
| EBITDA | $-50.00M | $3.51B |
| Pre-Tax Income | $-61.43M | $1.96B |
| Income Tax | $-813,000 | $333.00M |
| Net Income (Profit) | $-60.62M | $1.63B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RKLB | RTX |
|---|---|---|
| Cash & Equivalents | $303.15M | $5.16B |
| Total Current Assets | $724.85M | $52.92B |
| Total Current Liabilities | $348.12M | $52.62B |
| Long-Term Debt | $469.19M | $39.89B |
| Total Shareholders Equity | $431.29M | $63.34B |
| Retained Earnings | $-874.32M | $54.28B |
| Property, Plant & Equipment | $88.95M | $35.25B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RKLB | RTX |
|---|---|---|
| Operating Cash Flow | $-41.35M | $1.23B |
| Capital Expenditures | $-28.68M | N/A |
| Free Cash Flow | $-82.90M | $688.00M |
| Debt Repayment | $-2.96M | $-9.00M |
| Common Stock Repurchase | N/A | $-50.00M |
Short Interest & Institutional Ownership Analysis
| Metric | RKLB | RTX |
|---|---|---|
| Shares Short | 55.92M | 11.45M |
| Short Ratio | 2.10 | 1.98 |
| Short % of Float | 0.13% | 0.01% |
| Average Daily Volume (10 Day) | 13,672,272 | 4,342,010 |
| Average Daily Volume (90 Day) | 21,819,954 | 4,877,743 |
| Shares Outstanding | 504.45M | 1.33B |
| Float Shares | 424.08M | 1.22B |
| % Held by Insiders | 0.02% | 0.00% |
| % Held by Institutions | 0.63% | 0.83% |
Dividend Analysis & Yield Comparison: Rocket Lab USA vs RTX
| Metric | RKLB | RTX |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.89 |
| Last 12-Month Dividend Yield | N/A | 1.30% |
| 3-Year Avg Annual Dividend | N/A | $1.98 |
| 3-Year Avg Dividend Yield | N/A | 0.58% |
| 3-Year Total Dividends | N/A | $5.94 |
| Ex-Dividend Date | N/A | Feb 21, 2025 |